Jeff Geschwind, MD founded PreScience Labs (now Cage Pharma) to target cancer's metabolic pathways. His entrepreneurial spirit drives the quest for groundbreaking therapeutic options. https://www.scribd.com/document/900578221/Targeting-Tumor-Glycolysis-a-Promising-Frontier-in-Cancer-Therapy